Abstract
Pazopanib is a receptor kinase inhibitor of VEGF, PDGF and c-kit, whose anti-tumor activity results from the interference with the signallingcascades responsible for neoangiogenesis.
Pazopanib is a receptor kinase inhibitor of VEGF, PDGF and c-kit, whose anti-tumor activity results from the interference with the signallingcascades responsible for neoangiogenesis.